CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 8-K Event Acquisition or sale completed · Executive or director change · Bylaws or fiscal year change
- 8-K Event New debt or obligation · Delisting notice
- 8-K Event Material agreement · Bankruptcy
- 8-K Event Material agreement
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 8-K Event Material agreement
- 8-K Event Material agreement
- 4 Option exercise See Remarks acquired 35 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 35 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 35 shares (option exercise)
- 4 Option exercise CEO and President acquired 219 shares (option exercise)
- 4 Planned sale Chief Scientific Officer sold 6,845 shares at $1.09 ($7,427)
- 4 Planned sale See Remarks sold 6,560 shares at $1.08 ($7,111)
- 4 Planned sale Chief Financial Officer sold 6,845 shares at $1.09 ($7,427)
- 4 Planned sale CEO and President sold 19,419 shares at $1.09 ($21,108)
Page 1 of 34 · 672 filings